Optimal design of chemotherapy drug protocol for cancer treatment based on a new mathematical model

被引:4
|
作者
Department of Mechanical Engineering, K. N. Toosi University of Technology, P.O. Box 19395-1999, Tehran, Iran [1 ]
机构
[1] Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran
来源
Int. J. Model. Ident. Control | 2008年 / 2卷 / 146-153期
关键词
Cancer treatment; Chemotherapy drug protocol; GAs; Genetic algorithms; Optimal control;
D O I
10.1504/IJMIC.2008.022020
中图分类号
学科分类号
摘要
Cancer chemotherapy is the treatment of cancer using drug that kills the malignant cancer cells (tumours). In chemotherapy, the drug is delivered according to a schedule which specifies the cycles of application and rest time and the dosage of the drug which must be delivered. One of the major aims of chemotherapy is to eliminate the tumour cells after a fixed treatment with minimum adverse drug effects. This paper proposes an algorithm to design an optimal chemotherapy drug protocol. The target is to optimise the number of rests, the application course and the drug dosage. A new mathematical model is employed in the form of ordinary differential equations governing cancer growth on a cell population level. The model is modified by appending cumulative drug toxicity as an additional equation. An optimisation problem is formulated for optimal control with a set of dynamic equations in the state space form. A new objective function is considered to minimise the tumour size as well as drug toxicity under a set of constraints using a proposed genetic approach. Also, the drug resistant effect in the optimal treatment schedule is applied to the model as well. Finally, results are presented to demonstrate the efficiency of the proposed protocol in cancer treatment. © 2008, Inderscience Publishers.
引用
收藏
页码:146 / 153
页数:7
相关论文
共 50 条
  • [31] Optimal control design for drug delivery of immunotherapy in chemoimmunotherapy treatment
    Khalili, Pariya
    Vatankhah, Ramin
    COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2023, 229
  • [32] Mathematical Modeling of Tumor Growth, Drug-Resistance, Toxicity, and Optimal Therapy Design
    Hadjiandreou, Marios M.
    Mitsis, Georgios D.
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2014, 61 (02) : 415 - 425
  • [33] OPTIMAL CONTROL BASED IN A MATHEMATICAL MODEL APPLIED TO ROBOTIC ARMS
    De Jesus Rubio, Jose
    Torres, Cesar
    Aguilar, Carlos
    INTERNATIONAL JOURNAL OF INNOVATIVE COMPUTING INFORMATION AND CONTROL, 2011, 7 (08): : 5045 - 5062
  • [34] A new mathematical model studying imperfect vaccination: Optimal control analysis
    Mohammed-Awel, Jemal
    Numfor, Eric
    Zhao, Ruijun
    Lenhart, Suzanne
    JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS, 2021, 500 (02)
  • [35] Optimal Control Treatment Analysis for the Predator-Prey Chemotherapy Model
    Abdulrashid, Ismail
    Ghazzai, Hakim
    Han, Xiaoying
    Massoud, Yehia
    31ST INTERNATIONAL CONFERENCE ON MICROELECTRONICS (IEEE ICM 2019), 2019, : 296 - 299
  • [36] Optimal Control on Bladder Cancer Growth Model with BCG Immunotherapy and Chemotherapy
    Dewi, C.
    Trisilowati
    SYMPOSIUM ON BIOMATHEMATICS, 2015, 1651 : 53 - 58
  • [37] A mathematical model for cancer treatment based on combination of anti-angiogenic and immune cell therapies
    Nave, OPhir
    Sigron, Moria
    RESULTS IN APPLIED MATHEMATICS, 2022, 16
  • [38] Sensitivity analysis and optimal treatment control for a mathematical model of Human Papillomavirus infection
    Zhang, Kai
    Ji, Yunpeng
    Pan, Qiuwei
    Wei, Yumei
    Ye, Yong
    Liu, Hua
    AIMS MATHEMATICS, 2020, 5 (03): : 2646 - 2670
  • [39] The Design and Application of Nanomaterials as Drug Carriers in Cancer Treatment
    Hou, Jia
    Sun, Xiaoyan
    Huang, Ying
    Yang, Shaohua
    Liu, Junjie
    Feng, Changhao
    Ma, Jun
    Chen, Bin
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (36) : 6112 - 6135
  • [40] Mathematical model of STAT signalling pathways in cancer development and optimal control approaches
    Lee, Jonggul
    Lee, Donggu
    Kim, Yangjin
    ROYAL SOCIETY OPEN SCIENCE, 2021, 8 (09):